AtriCure | ATRC - PE价格收益



金融业
股票价格
USD
资产
USD 676.64M
现金及等价物
USD 167.79M
销售成本
USD 34.98M
流动资产
USD 345.53M
流动负债
USD 81.92M
债务
USD 71.78M
股息收益率
0
EBIT
USD 9.67M
EBITDA
USD 27.29M
员工
1.3K
EPS每股收益
USD 0.18
股本和储备
USD 516.43M
销售毛利
USD 109.31M
债务利息支出
USD 1.21M
利息收入
USD 1.25M
贷款资金
USD 61M
市值
USD 2.6B
净收入
USD 8.96M
营业费用
USD 143.94M
营业利润
USD 9.67M
普通股股本
USD 50.64M
PE价格收益
129.01
税前利润
USD 394K
销售收入
USD 153.6M
销售和管理费用
USD 82.56M
股票
USD 83.93M
贸易债权人
USD 78.74M
应收帐款人
USD 79.98M


Pe 更改 日
Abbott 23.85 1.08 2026-06
Artivion 212.38 16.51 2025-12
AtriCure 129.01 94.86 2026-06
Baxter International 151.95 65.95 2026-06
Becton, Dickinson and Co. 16.04 9.65 2026-06
Boston Scientific 17.86 14.49 2026-06
Cooper Companies 24.8 1.53 2026-06
Dexcom 24.61 0.12 2026-06
Edwards Lifesciences 30.77 3.9 2026-06
Globus Medical 22.31 12.99 2026-06
Inogen 69.33 30.67 2021-09
Insulet 29.66 9.17 2026-06
Integra LifeSciences 10.28 5.21 2026-06
Intuitive Surgical 44.59 11.23 2026-06
J&J 29.43 4.9 2026-06
Medtronic 18.15 1.51 2026-06
Merit Medical Systems 32.36 12.84 2026-03
ResMed 18.29 2.92 2026-06
Stryker 27.46 2.98 2026-06
Tandem Diabetes Care 681.05 189.32 2022-03
Teleflex 89.77 40.52 2026-06
Zimmer Biomet Holdings 17.33 8.14 2026-06